Sanofi-Regeneron Dupixent data reinforce use in atopic dermatitis patients with skin of color Ruchika Sharma9 Jun 2025 1:12 PM ISTParis: Sanofi has announced that results from the DISCOVER phase 4, single-arm, open-label study assessing Dupixent (dupilumab) in adults and...
Simultaneous treatment start with Finerenone and SGLT-2-inhibitor demonstrated positive data in patients with CKD associated with type 2 diabetes: Bayer Ruchika Sharma9 Jun 2025 10:00 AM ISTBerlin: Bayer has announced results of the Phase II CONFIDENCE study, demonstrating that simultaneous initiation of finerenone (Kerendia)...
Banned medicated soap found in Karimnagar medical shop raid Ruchika Sharma8 Jun 2025 4:15 PM ISTTelangana: Drugs Control Administration, Telangana, has seized a banned drug, 'Medicated Skin Care Soap containing Permethrin IP 1.0%, Cetrimide IP...
CDSCO Panel Approves Updated Prescribing Information for AstraZeneca's Rosuvastatin (Crestor) Dr. Divya Colin8 Jun 2025 12:43 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has granted approval for the updated...
Sanofi launches 2025 Global Employee Stock Purchase Plan Ruchika Sharma8 Jun 2025 12:30 PM ISTParis: Sanofi's global employee shareholder plan, Action 2025, opens on June 10, 2025, to around 70,000 employees in 55 countries.In 2024 alone,...
Bayer arm secures exclusive worldwide rights to develop, commercialize clinical-stage WRN Inhibitor Ruchika Sharma8 Jun 2025 10:00 AM ISTSan Diego: Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of...
Lupin bags tentative nod from USFDA for partial-onset seizures drug Oxcarbazepine ER Ruchika Sharma7 Jun 2025 5:24 PM ISTMumbai: Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for...
Wockhardt seeks DCGI nod for Zaynich Ruchika Sharma7 Jun 2025 3:33 PM ISTDrugmaker Wockhardt on Friday said that it has filed for regulatory approval of its Zaynich with the Drug Controller General of India (DCGI),...
Reckitt names Ravi Bhatnagar as Director Corporate Communications and Corporate Affairs (South Asia, MENARP and Africa) Ruchika Sharma7 Jun 2025 2:38 PM ISTReckitt has appointed Ravi Bhatnagar as its new Director of Corporate Communications and Corporate Affairs for South Asia, MENARP, and...
Suspected spurious drugs worth Rs 5.21 lakh seized in Hyderabad Ruchika Sharma6 Jun 2025 5:30 PM ISTTelangana: In a raid conducted at the residence of a habitual offender in Hyderabad, the Drugs Control Administration, Telangana has...
Zydus Lifesciences venture capital arm to acquire stake in Agenus for USD 16 million Ruchika Sharma6 Jun 2025 3:05 PM ISTPennington: Zynext Ventures USA LLC, the venture capital arm of Zydus Lifesciences Limited, has entered into Securities Purchase...
AstraZeneca Calquence based regimens approved in EU for previously untreated chronic lymphocytic leukaemia Ruchika Sharma6 Jun 2025 12:28 PM ISTA fixed-duration regimen of AstraZeneca's Calquence (acalabrutinib) in combination with venetoclax, with or without obinutuzumab, has received...
